WallStreetZenWallStreetZen

NASDAQ: XGN
Exagen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for XGN

Based on 1 analyst offering 12 month price targets for Exagen Inc.
Min Forecast
$6.00+226.09%
Avg Forecast
$6.00+226.09%
Max Forecast
$6.00+226.09%

Should I buy or sell XGN stock?

Based on 1 analyst offering ratings for Exagen Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their XGN stock forecasts and price targets.

XGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-09-26

1 of 1

Forecast return on equity

Is XGN forecast to generate an efficient return?
Company
N/A
Industry
9.48%
Market
39.36%

Forecast return on assets

Is XGN forecast to generate an efficient return on assets?
Company
N/A
Industry
3.51%

XGN revenue forecast

What is XGN's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$50.2M-2.69%
Avg 2 year Forecast
$55.3M+7.06%
Avg 3 year Forecast
$66.6M+29.02%
XGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XGN revenue growth forecast

How is XGN forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
4.94%
Industry
-0.03%
Market
6.57%
XGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XGN vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
XGN$1.84$6.00+226.09%Strong Buy
OCX$3.80$3.87+1.76%Buy
AWH$3.20$4.80+50.00%Buy
LMDX$0.11$0.80+640.74%Buy
CNTG$1.26$1.50+19.05%Buy
View Top Diagnostic & Research Stocks

Exagen Stock Forecast FAQ

Is Exagen Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: XGN) stock is to Strong Buy XGN stock.

Out of 1 analyst, 1 (100%) are recommending XGN as a Strong Buy, 0 (0%) are recommending XGN as a Buy, 0 (0%) are recommending XGN as a Hold, 0 (0%) are recommending XGN as a Sell, and 0 (0%) are recommending XGN as a Strong Sell.

If you're new to stock investing, here's how to buy Exagen stock.

What is XGN's revenue growth forecast for 2023-2025?

(NASDAQ: XGN) Exagen's forecast annual revenue growth rate of 4.94% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of -0.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.57%.

Exagen's revenue in 2023 is $51,620,000.On average, 3 Wall Street analysts forecast XGN's revenue for 2023 to be $856,263,028, with the lowest XGN revenue forecast at $852,291,350, and the highest XGN revenue forecast at $860,814,264. On average, 3 Wall Street analysts forecast XGN's revenue for 2024 to be $942,054,675, with the lowest XGN revenue forecast at $927,292,989, and the highest XGN revenue forecast at $952,861,729.

In 2025, XGN is forecast to generate $1,135,252,078 in revenue, with the lowest revenue forecast at $1,135,252,078 and the highest revenue forecast at $1,135,252,078.

What is XGN's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: XGN) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 3.51%.

What is XGN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year XGN price target, the average XGN price target is $6.00, with the highest XGN stock price forecast at $6.00 and the lowest XGN stock price forecast at $6.00.

The Wall Street analyst predicted that Exagen's share price could reach $6.00 by Sep 26, 2024. The average Exagen stock price prediction forecasts a potential upside of 226.09% from the current XGN share price of $1.84.

What is XGN's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: XGN) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.